KORU Medical Systems, Inc. Common Stock (DE) (KRMD) Stock Price

KRMDStock

$3.00−25.37%52W

Market Cap$138.52M

P/E—

PEG Ratio—

Div yield—

Beta0.52

KRMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-40.14%

Price vs S&P 500 (4W)-5.80%

VGM Score43.17

P/CF (Annual)299.55x

Book Value / Share (Quarterly)$0.39

P/TBV (Annual)16.45x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.81%

Cash Flow / Share (Quarterly)$0.01

Price vs S&P 500 (YTD)-60.29%

Gross Margin (TTM)62.43%

Net Profit Margin (TTM)-4.03%

EPS (TTM)$-0.04

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$-0.04

Revenue Growth (5Y)11.21%

EPS (Annual)$-0.06

ROI (Annual)-15.29%

Gross Margin (Annual)62.26%

Net Profit Margin (5Y Avg)-24.61%

Cash / Share (Quarterly)$0.18

Revenue Growth QoQ (YoY)18.15%

ROA (Last FY)-9.35%

Revenue Growth TTM (YoY)22.41%

EBITD / Share (TTM)$-0.02

ROE (5Y Avg)-31.84%

Operating Margin (TTM)-3.66%

Cash Flow / Share (Annual)$-0.01

P/B Ratio7.67x

P/B Ratio (Quarterly)10.69x

Net Income / Employee (Annual)$-36,100

EV / Revenue (TTM)2.89x

Net Interest Coverage (TTM)-317.00x

ROA (TTM)-6.51%

EV / EBITDA (TTM)931.77x

EPS Incl Extra (Annual)$-0.06

Current Ratio (Annual)2.44x

Quick Ratio (Quarterly)2.00x

3-Month Avg Trading Volume0.22M

52-Week Price Return-25.37%

Revenue / Employee (TTM)$617,900

Tangible BV / Share (Quarterly)$0.36

P/S Ratio (Annual)3.37x

Asset Turnover (Annual)1.46x

52-Week High$6.61

Operating Margin (5Y Avg)-26.19%

EPS Excl Extra (Annual)$-0.06

CapEx CAGR (5Y)-2.03%

Tangible BV CAGR (5Y)-14.26%

26-Week Price Return-30.23%

Quick Ratio (Annual)1.88x

13-Week Price Return-27.01%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)2.72x

Enterprise Value$130.45M

Revenue / Share Growth (5Y)9.08%

Asset Turnover (TTM)1.61x

Book Value / Share Growth (5Y)-15.15%

Revenue / Employee (Annual)$563,400

Inventory Turnover (Annual)4.79x

Pretax Margin (Annual)-6.36%

Cash / Share (Annual)$0.19

3-Month Return Std Dev41.83%

Gross Margin (5Y Avg)59.59%

Net Income / Employee (TTM)$-24,900

ROE (Last FY)-15.47%

Net Interest Coverage (Annual)-189.80x

EPS Basic Excl Extra (Annual)$-0.06

P/FCF (TTM)203.89x

Receivables Turnover (TTM)9.06x

EV / Free Cash Flow (TTM)537.02x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.04

Receivables Turnover (Annual)6.71x

ROI (TTM)-10.45%

P/S Ratio (TTM)3.07x

Pretax Margin (5Y Avg)-24.80%

Revenue / Share (Annual)$0.89

Tangible BV / Share (Annual)$0.35

Price vs S&P 500 (52W)-40.91%

Year-to-Date Return-48.36%

5-Day Price Return1.01%

EPS Normalized (Annual)$-0.06

ROA (5Y Avg)-22.28%

Net Profit Margin (Annual)-6.41%

Month-to-Date Return2.39%

Cash Flow / Share (TTM)$-0.17

EBITD / Share (Annual)$-0.05

Operating Margin (Annual)-7.23%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)99.58x

ROI (5Y Avg)-30.89%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.04

P/TBV (Quarterly)11.77x

P/B Ratio (Annual)15.79x

Inventory Turnover (TTM)4.01x

Pretax Margin (TTM)-4.01%

Book Value / Share (Annual)$0.37

Price vs S&P 500 (13W)-29.69%

Beta0.52x

P/FCF (Annual)138.52x

Revenue / Share (TTM)$0.91

ROE (TTM)-10.63%

52-Week Low$2.86

vGradeD

gGradeB

mGradeC

vgmGradeC

KRMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.01	$0.02	+500.00%(+$0.03)
Q1 2026	May 6, 2026	-$0.01	$0.00	+100.00%(+$0.01)
Q4 2025	Mar 12, 2026	-$0.01	$0.01	+180.00%(+$0.02)
Q3 2025	Nov 12, 2025	-$0.02	$0.00	+100.00%(+$0.02)
Q2 2025	Aug 6, 2025	-$0.02	$0.01	+150.00%(+$0.03)

KRMD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
KRMDKORU Medical Systems, Inc. Common Stock (DE)	D	B	C	3.1x	11.2%	62.4%	-3.7%	$3.00
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About KORU Medical Systems, Inc. Common Stock (DE)

KORU Medical Systems develops and manufactures subcutaneous infusion devices designed to deliver immunoglobulin therapies for patients with primary immunodeficiencies and chronic inflammatory demyelinating polyneuropathy. The company's flagship FREEDOM Infusion System product line includes the FREEDOM60 and FreedomEdge syringe drivers along with complementary delivery components. KORU serves the home and clinical infusion therapy market for chronic immunological disorders.

KRMD Next Earnings Report

Report dateNov 11, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.02

Revenue estimate$11.33M

Also reporting on Nov 11, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

KRMD Insider Transactions

BuySep 8, 2026
KALBERMATTEN ADAM R
Officer
Shares: 32,000Value: $101,120

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

RXSTRxSight, Inc. Common StockOphthalmic Goods
INGNInogen IncOrthopedic & Prosthetic Devices
INTTinTEST CorporationInstruments for Measuring
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary SharesOrthopedic & Prosthetic Devices
HURCHurco Cos IncIndustrial Instruments
QTRXQuanterix Corporation Common StockLab Analytical Instruments
OWLTOwlet, Inc.Measuring & Controlling Devices
SEERSeer, Inc. Class A Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$2.86

High$6.61